Noyd David H, Bailey Anna, Janitz Amanda, Razzaghi Talayeh, Bouvette Sharon, Beasley William, Baker Ashley, Chen Sixia, Bard David
Ben Towne Center for Childhood Cancer and Blood Disorders Research and the Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA.
College of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
J Adolesc Young Adult Oncol. 2025 Mar 25. doi: 10.1089/jayao.2024.0151.
Cardiovascular risk factors (CVRFs) later in life potentiate risk for late cardiovascular disease (CVD) from cardiotoxic treatment among survivors. This study evaluated the association of baseline CVRFs and CVD in the early survivorship period. This analysis included patients ages 0-29 at initial diagnosis and reported in the institutional cancer registry between 2010 and 2017 ( = 1228). Patients who died within 5 years ( = 168), those not seen in the oncology clinic ( = 312), and those with CVD within one year of diagnosis ( = 17) were excluded. CVRFs (hypertension, diabetes, dyslipidemia, and obesity) within 1 year of initial diagnosis were constructed and extracted from the electronic health record based on discrete observations, ICD9/10 codes, and RxNorm codes for antihypertensives. Among survivors ( = 731), 10 incident cases (1.4%) of CVD were observed between 1 and 5 years after the initial diagnosis. Public health insurance ( = 0.04) and late effects risk strata ( = 0.01) were positively associated with CVD. Among survivors with public insurance ( = 495), two additional cases of CVD were identified from claims data with an incidence of 2.4%. Survivors from rural areas had a 4.1 times greater risk of CVD compared with survivors from urban areas (95% CI: 1.1-15.3), despite adjustment for late effects risk strata. Clinically computable phenotypes for CVRFs among survivors through informatics methods were feasible. Although CVRFs were not associated with CVD in the early survivorship period, survivors from rural areas were more likely to develop CVD.
晚年的心血管危险因素(CVRF)会增加幸存者因心脏毒性治疗而患晚期心血管疾病(CVD)的风险。本研究评估了早期存活期基线CVRF与CVD之间的关联。该分析纳入了2010年至2017年间在机构癌症登记处报告的初诊时年龄为0至29岁的患者(n = 1228)。排除了5年内死亡的患者(n = 168)、未在肿瘤诊所就诊的患者(n = 312)以及诊断后1年内患有CVD的患者(n = 17)。根据离散观察、ICD9/10编码和抗高血压药物的RxNorm编码,从电子健康记录中构建并提取初诊后1年内的CVRF(高血压、糖尿病、血脂异常和肥胖)情况。在幸存者(n = 731)中,初诊后1至5年间观察到10例CVD新发病例(1.4%)。公共医疗保险(P = 0.04)和晚期效应风险分层(P = 0.01)与CVD呈正相关。在有公共保险的幸存者(n = 495)中,从理赔数据中又识别出2例CVD病例,发病率为2.4%。尽管对晚期效应风险分层进行了调整,但农村地区的幸存者患CVD的风险是城市地区幸存者的4.1倍(95%CI:1.1 - 15.3)。通过信息学方法在幸存者中计算CVRF的临床可行表型是可行的。虽然在早期存活期CVRF与CVD无关,但农村地区的幸存者更易患CVD。